Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1

Virology

Volumn 328, Issue 1, 2004, Pages 1-6

  Kiselyeva, Yana ^a   Ito, Yoshinori ^a   Lima, Rosangela G ^a   Grivel, Jean Charles ^a   Das, Atze T ^b   Berkhout, Ben ^b,c   Margolis, Leonid B ^a,c  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CD4 + T cell; HIV 1; Human lymphoid tissue

Indexed keywords

CD4 ANTIGEN; DOXYCYCLINE; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; INOCULATION; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRION;

ANTI-INFECTIVE AGENTS; CELLS, CULTURED; DOXYCYCLINE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; TIME FACTORS; VIRULENCE; VIRUS LATENCY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 4544259896     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.07.014     Document Type: Article

References (32)

1. A.D. Badley, J.A. McElhinny, P.J. Leibson, D.H. Lynch, M.R. Alderson, and C.V. Paya Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes J. Virol. 70 1 1996 199 206
2. A.D. Badley, A.A. Pilon, A. Landay, and D.H. Lynch Mechanisms of HIV-associated lymphocyte apoptosis Blood 96 9 2000 2951 2964
3. N.K. Banda, J. Bernier, D.K. Kurahara, R. Kurrle, N. Haigwood, R.P. Sekaly, and T.H. Finkel Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis J. Exp. Med. 176 4 1992 1099 1106
4. B. Berkhout, K. Verhoef, G. Marzio, B. Klaver, M. Vink, X. Zhou, and A.T. Das Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine J. NeuroVirol. 8 Suppl. 2 2002 134 137
5. C.R. Casella, and T.H. Finkel Mechanisms of lymphocyte killing by HIV Curr. Opin. Hematol. 4 1 1997 24 31
6. A.T. Das, X. Zhou, M. Vink, B. Klaver, and B. Berkhout Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine Exp. Rev. Vaccines 1 3 2002 293 301
7. A.T. Das, X. Zhou, V. Monique, B. Klaver, K. Verhoef, G. Marzio, and B. Berkhout Viral evolution as a tool to improve the tetracycline-regulated gene expression system J. Biol. Chem. 279 18 2004 1877 1882
8. R.W. Doms, and D. Trono The plasma membrane as a combat zone in the HIV battlefield Genes Dev. 14 21 2000 2677 2688
9. + T cells by a Fas-independent mechanism J. Exp. Med. 187 7 1998 1113 1122
10. J.V. Garcia, and A.D. Miller Serine phosphorylation-independent downregulation of cell-surface CD4 by nef Nature 350 6318 1991 508 511
11. + T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1 AIDS Res. Hum. Retroviruses 13 6 1997 461 471
12. M.L. Gougeon, and L. Montagnier Apoptosis in AIDS Science 260 5112 1993 1269 1270
13. J.C. Grivel, and L.B. Margolis CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue Nat. Med. 5 3 1999 344 346
14. J.C. Grivel, N. Malkevitch, and L. Margolis Human immunodeficiency virus type 1 induces apoptosis in CD4(+) but not in CD8(+) T cells in Ex vivo-infected human lymphoid tissue [In Process Citation] J. Virol. 74 17 2000 8077 8084
15. + T lymphocytes survive in HIV-infected human lymphoid tissue AIDS Res. Hum. Retroviruses 19 3 2003 211 216
16. + T-cell depletion in HIV infection: are we closer to understanding the cause? Nat. Med. 8 4 2002 319 323
17. G. Herbein, C. Van Lint, J.L. Lovett, and E. Verdin Distinct mechanisms trigger apoptosis in human immunodeficiency virus type 1-infected and in uninfected bystander T lymphocytes J. Virol. 72 1 1998 660 670
18. J.A. Hoxie, J.D. Alpers, J.L. Rackowski, K. Huebner, B.S. Haggarty, A.J. Cedarbaum, and J.C. Reed Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV Science 234 4780 1986 1123 1127
19. K.T. Jeang, B. Berkhout, and B. Dropulic Effects of integration and replication on transcription of the HIV-1 long terminal repeat J. Biol. Chem. 268 33 1993 24940 24949
20. J.A. LaBonte, T. Patel, W. Hofmann, and J. Sodroski Importance of membrane fusion mediated by human immunodeficiency virus envelope glycoproteins for lysis of primary CD4-positive T cells J. Virol. 74 22 2000 10690 10698
21. + target cells Res. Virol. 146 1 1995 5 17
22. U. Mahlknecht, and G. Herbein Macrophages and T-cell apoptosis in HIV infection: a leading role for accessory cells? Trends Immunol. 22 5 2001 256 260
23. N. Malkevitch, D.H. McDermott, Y. Yi, J.C. Grivel, D. Schols, E. De Clercq, P.M. Murphy, S. Glushakova, R.G. Collman, and L. Margolis Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue Virology 281 2 2001 239 247
24. L. Meyaard, S.A. Otto, R.R. Jonker, M.J. Mijnster, R.P. Keet, and F. Miedema Programmed death of T cells in HIV-1 infection Science 257 5067 1992 217 219
25. C.A. Muro-Cacho, G. Pantaleo, and A.S. Fauci Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden J. Immunol. 154 10 1995 5555 5566
26. + T cells apoptosis: a possible mechanism of bystander cell death in HIV infection J. Immunol. 158 5 1997 2456 2463
27. G. Pantaleo, and A.S. Fauci New concepts in the immunopathogenesis of HIV infection Annu. Rev. Immunol. 13 1995 487 512
28. G. Pantaleo, C. Graziosi, and A.S. Fauci Virologic and immunologic events in primary HIV infection Springer Semin. Immunopathol. 18 3 1997 257 266
29. A.W. Sylwester, J.C. Grivel, W. Fitzgerald, J.L. Rossio, J.D. Lifson, and L.B. Margolis CD4(+) T-lymphocyte depletion in human lymphoid tissue ex vivo is not induced by noninfectious human immunodeficiency virus type 1 virions J. Virol. 72 11 1998 9345 9347
30. K. Verhoef, G. Marzio, W. Hillen, H. Bujard, and B. Berkhout Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat J. Virol. 75 2 2001 979 987
31. Y. Yang, and J.D. Ashwell Exploiting the apoptotic process for management of HIV: are we there yet? Apoptosis 6 1â€"2 2001 139 146
32. J.A. Zack, S.J. Arrigo, S.R. Weitsman, A.S. Go, A. Haislip, and I.S. Chen HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure Cell 61 2 1990 213 222